US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist
  • 6.340
  • +0.200+3.26%
Close Mar 4 16:00 ET
  • 6.340
  • 0.0000.00%
Post 16:05 ET
148.30MMarket Cap-5.71P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-13.32%19.85M
-6.07%6.45M
-29.21%4.36M
-19.56%4.64M
7.19%4.4M
19.04%22.9M
1.30%6.87M
3.70%6.16M
61.54%5.77M
39.25%4.1M
Selling and administrative expenses
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
-General and administrative expense
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
17.91%1.67M
41.39%1.51M
52.11%1.73M
Research and development costs
-16.01%12.92M
5.42%4.5M
-37.16%2.82M
-30.95%2.94M
12.38%2.66M
16.28%15.38M
-3.00%4.27M
-0.75%4.49M
70.14%4.26M
31.14%2.37M
Operating profit
13.32%-19.85M
6.07%-6.45M
29.21%-4.36M
19.56%-4.64M
-7.19%-4.4M
-19.04%-22.9M
-1.30%-6.87M
-3.70%-6.16M
-61.54%-5.77M
-39.25%-4.1M
Net non-operating interest income expense
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
332.69%225K
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
Non-operating interest income
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
332.69%225K
327.52%637K
197.56%244K
354.10%277K
1,500.00%64K
2,500.00%52K
Other net income (expense)
Income before tax
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
Income tax
Net income
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
Net income continuous Operations
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
Minority interest income
Net income attributable to the parent company
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
Basic earnings per share
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
Diluted earnings per share
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
11.90%-0.37
-35.71%-0.38
15.63%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -13.32%19.85M-6.07%6.45M-29.21%4.36M-19.56%4.64M7.19%4.4M19.04%22.9M1.30%6.87M3.70%6.16M61.54%5.77M39.25%4.1M
Selling and administrative expenses -7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M
-General and administrative expense -7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M17.91%1.67M41.39%1.51M52.11%1.73M
Research and development costs -16.01%12.92M5.42%4.5M-37.16%2.82M-30.95%2.94M12.38%2.66M16.28%15.38M-3.00%4.27M-0.75%4.49M70.14%4.26M31.14%2.37M
Operating profit 13.32%-19.85M6.07%-6.45M29.21%-4.36M19.56%-4.64M-7.19%-4.4M-19.04%-22.9M-1.30%-6.87M-3.70%-6.16M-61.54%-5.77M-39.25%-4.1M
Net non-operating interest income expense 32.97%847K-17.62%201K-25.63%206K235.94%215K332.69%225K327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K
Non-operating interest income 32.97%847K-17.62%201K-25.63%206K235.94%215K332.69%225K327.52%637K197.56%244K354.10%277K1,500.00%64K2,500.00%52K
Other net income (expense)
Income before tax 14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M
Income tax
Net income 14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M
Net income continuous Operations 14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M
Minority interest income
Net income attributable to the parent company 14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M-0.07%-5.88M-59.93%-5.71M-37.58%-4.05M
Basic earnings per share 22.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.267.41%-0.255.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27
Diluted earnings per share 22.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.267.41%-0.255.30%-1.4314.58%-0.4111.90%-0.37-35.71%-0.3815.63%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+9.66%
Coinbase
COIN
+3.30%
Alphabet-A
GOOGL
+2.34%
Alphabet-C
GOOG
+2.34%
NVIDIA
NVDA
+1.69%

Unlock the Full List